Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion type Assertion NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_head.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion wasGeneratedBy ECO_0000203 NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_provenance.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion wasDerivedFrom befree-2016 NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_provenance.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion SIO_000772 24806995 NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_provenance.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion evidence source_evidence_literature NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_provenance.
- NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_assertion description "[Activation of FOXO1 and 3a and a decreased expression of their target gene Cyclin D1 were also observed after 6 days of in vivo treatment with dasatinib in a CML transgenic mouse model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180412.RA1jwopYV_R6Q9TdM4x6IOyik2JxHzWnzWijEriu3-mx0130_provenance.